Previous Speakers

Dr. Dana Haddad

Head of Breast Imaging HealthBay Polyclinic, UAE

Dr.Michael Retsky

Associate Professor University College London, USA

Lori A. Loan

Associate Professor University of Alabama , USA

Nandini N.M

JSS Academy Of Higher Education And Research, India

Xu Dong Zhang

University of Newcastle Australia

Daphne Gschwantler-Kaulich

Medical University of Vienna , Austria

Maude Hébert

University of Quebec in Trois-Rivieres , Canada

Pedro Sanchez Rovia

Xanit International Hospital , Spain

Recommended Global Oncology & Cancer Webinars & Conferences

Europe & UK

Breast Pathology 2024, Italy Cancer Science 2024, Italy RADIOLOGY AND ONCOLOGY 2024, France Oncology 2024, Switzerland Breast Cancer 2024, Switzerland

Asia Pacific & Middle East

World Cancer 2024, UAE

Canada

Cancer Biology 2024, UK

Cancer Biology 2023

About Conferences

Conference Series welcomes all the speakers and delegates from around the world to attend "International Conference on Cancer Biology and Therapeutics” (CANCER BIOLOGY 2023) November 08-09, 2023 Budapest, Hungary. This incorporates provoke keynote introductions, Oral talks, Poster introductions and Exhibitions.

CANCER BIOLOGY 2023 is an exceptional occasion which encourages world-renowned researchers, Doctors, scientists, Students to gather and explore Challenges and solutions faced by the Social Community.

Yound Scientist Benfits :

Our conferences provide best Platform for your research through oral presentations.
Share the ideas with both eminent researchers and mentors.
Young Scientist Award reorganization certificate and memento to the winners
Young Scientists will get appropriate and timely information by this Forum.
Platform for collaboration among young researchers for better development
Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Participation Options :

CANCER BIOLOGY 2023 provides the participants with different modes or ways to participate such as Delegate or Speaker under ACADEMIC / STUDENT / BUSINESS Category.

Keynote speaker: 30-45 minutes
Speaker (oral presentation): 20-30 minutes (only one person can present)
Speaker (workshop): 45-50 minutes (more than 1 can present)
Speaker (special session): 45-50 minutes (more than 1 can present)
Speaker (symposium): more than 45 minutes (more than 1 can present)
Delegate(only registration): will have access to all the sessions with all the benefits of registration
Poster presenter: can present a poster and enjoy the benefits of delegate
Remote attendance: can participate via video presentation or e-poster presentation
Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes
Media partner
Sponsor
Collaborator

Target Audience :

Doctors

Dietician

Health care professionals

Nurse practitioners

Health care administrators

Physicians

Health care associations and societies

Health care universities

Scientists

Professors

Associate professors

Health care industries

Medical colleges and Hospitals

Business Analysts

Family medicine specialists

Healthcare Investors

Foundation Leaders

Researchers

Sessions/Tracks

Track 1: Cancer Biology: Cancer frameworks technology consists of the utilization of frameworks technological know-how approaches to cope with tumor inquire about, preserving in thoughts the quit aim to ponder the infection as a complex versatile framework with growing properties at one-of-a-kind natural scales. All of the extra unequivocally, in light of the truth that increase traverses numerous organic, spatial and brief scales, correspondence and enter units over the scales make a profoundly complex dynamic framework.

Track 2: Radiation Therapy: Radiation Therapy is a type of cancer treatment that is used to treat the cancer patients. In radiation therapy oncologist uses beams of intense energy to kill cancer cells. Radiation therapy commonly uses X-rays, but protons or other types of energy also can be used. "Radiation therapy" commonly refers to external beam radiation therapy.

Cancer Societies : Dutch Society for Surgical Oncology | German Society of Radiation Oncology | Childhood Cancer Research Group| Association of Population-based Cancer Registries in Germany | French Society of Radiation Oncology |

Track 3: Cancer Science: Malignancy Science is a wide-going field that manages disease research and treatment. Malignant growth, when estimated as a lethal ailment, however at this point with an advancement in the disease inquire about the circumstance has changed. It is estimated as an enormous accomplishment as there are various treatments accessible presently to treat and analyze the malignant growth. The targeted cancer therapy is one of the premium therapies in treating cancer as it involves, the treating of the cancer cells by targeting and inhibiting the specific molecules that are need for the tumor progression.

Track 4: Cancer Pharmaceutics : The finding of new disease medications occurs in an assortment of ways like an Accidental revelation if there should be an occurrence of the Nitrogen mustard, relies on the Testing plants, parasites, and creatures and checking on the science of threatening cells. Extreme scientists who are generating cancer drugs twitch by equating the genetics originated in DNA and cellular processes of cancer cells to healthy cells. These identify authoritative phases in the cancer growth procedure that a drug could possibly fix. Once drugs are shaped, scientists test them on humanoid tumor cells in the lab to see as they halt the growth of cancer cells.

Track 5: Innovations of Cancer: Cancer Innovation may be described clearly as a "new idea, tool or approach". However, innovation is often additionally regarded as the utility of better answers that meet new requirements, unarticulated desires, or current marketplace needs. This is executed through more-powerful merchandise, methods, offerings, technologies, or business fashions which can be without difficulty available to markets, governments and society. The term "innovation" may be defined as something unique and more effective and, as a result, new, that "breaks into" the market or society.

Track 6: Leukemia: Leukemia, also spelled leukemia, is a group of cancers that usually begin within the bone marrow and result in high numbers of atypical white blood cells. Those white blood cells aren't fully advanced and are referred to as blasts or leukemia cells. Signs and symptoms can also encompass bleeding and bruising troubles, feeling worn-out, fever, and an accelerated threat of infections. Those signs occur because of a lack of normal blood cells. Prognosis is usually made by means of blood tests or bone marrow biopsy.

Track 7: Metabolites in Cancer: Oncogenomics is a sub field of genomics that portrays disease related qualities. It centers on genomic, epigenomic and transcript adjustments in growth. Malignancy is a hereditary malady caused by assemblage of DNA changes and epigenetic adjustments prompting uncontrolled cell multiplication and neoplasm advancement. The objective of oncogenomics is to recognize new oncogenes or tumor silencer qualities that may give new dreams into disease conclusion, expecting clinical aftereffect of developments and new focuses for malignancy treatments.

Track 8: Vaccines involvement in Cancer: Growth immunizations may be large or either treats existing malignancy or counteracts improvement of a disease. In tumor treatment antibodies are comprised of cancer cells, parts of cells, or unadulterated antigens. Now and then a patient's own resistant cells are evacuated and presented to these substances in the lab to make the antibodies.

Track 9: Oral and Oropharyngeal Cancer: The cancer conference session on Oral and Oropharyngeal Cancer provided a comprehensive overview of the latest developments and breakthroughs in the diagnosis, treatment, and prevention of these types of cancer. It showcased the importance of personalized care and the need for continued research and clinical trials to improve outcomes for patients with oral and oropharyngeal cancer.

Track 10: Regenerative Medicine: Regenerative medicine is a rapidly evolving field that focuses on harnessing the body's natural ability to repair and regenerate damaged tissues and organs. In the context of cancer treatment, regenerative medicine approaches are being developed to help repair the damage caused by cancer and its treatments, as well as to regenerate healthy tissues and organs that have been affected by cancer.

Track 11: Tumor Microenvironment: The scientific session on the role of the tumor microenvironment focuses on understanding the complex interactions between cancer cells and their surrounding microenvironment, including the stromal cells, extracellular matrix, blood vessels, immune cells, and signaling molecules. The session aims to explore the influence of the tumor microenvironment on cancer initiation, progression, metastasis, treatment response, and resistance, as well as its potential as a therapeutic target.

Track 12: Quality of Life & Supportive Care: The scientific session on quality of life and supportive care focuses on addressing the multidimensional aspects of patients' well-being and providing comprehensive support throughout their cancer journey. The session aims to explore various strategies, interventions, and research related to improving the quality of life and providing supportive care services to individuals affected by cancer.

Track 13 : Hormonal Therapy: Hormonal therapy is the use of hormones in medical treatment. Treatment with hormone antagonists may also be referred to as hormonal therapy or antihormone therapy. Androgen replacement therapy (ART) and transgender hormone therapy. In women, the body of the women is comprised of ovaries. Estrogen creates hormone receptor that prompts the positive bosom malignancy development. Subsequently, gathering the measure of estrogen can abbreviate the danger of an early life-arrange. It is important to realize that hormonal treatment isn't hormone substitution treatment (HRT).

Track 14: Neonatal and Pediatric Oncology: Neonatal & Pediatric Oncology is the term used to comprise all malignant conditions among neonates & children with cancer. The most common childhood cancer is, Neuroblastoma, Retinoblastoma, Wilms tumor and brain tumors, such as gliomas. Childhood cancers are very rare and may differ from adult cancers in the way they grow, spread, treated, and respond to treatment.

Cancer Societies: Dutch Society for Surgical Oncology | Childhood Cancer Research Group | Association of Population-based Cancer Registries in Germany | French Society of Radiation Oncology |

Track 15: Gynecology, Infectious Diseases and Oncology: Contaminations in the female genitalia and the extra sex organs are regularly known as Gynecologic Infectious Diseases. A portion of the irresistible infections is Vulvovaginitis, Cervicitis, Pelvic Inflammatory Diseases, and Sexually Transmitted Diseases. Gynecologic Oncology is a specific field that arrangements with growths relating to the female genitalia and conceptive framework.

Track 16: Pathology in Cancer: Pathologists are among the most important members of a patient’s cancer care team. They work to diagnose and determine the stage of cancer, setting the course for what comes next in the treatment journey. Pathology is the service that handles the blood samples and the cells and tissues removed from suspicious ‘lumps and bumps’. Cancer pathology’s key role in diagnosing and treating a complex disease, it’s important to stay up to date on new technologies and breakthroughs that continue to shape the ever-evolving landscape of cancer care.

Track 17: Surgical Oncology: Surgical oncology is a specialized field of medicine that focuses on the surgical management of cancer. Surgeons who specialize in this field are known as surgical oncologists. They work closely with other members of a cancer treatment team, such as medical oncologists, radiation oncologists, and pathologists, to provide comprehensive care for cancer patients. Surgical oncologists perform various types of cancer surgeries, such as biopsies, tumor removals, lymph node dissections, and reconstructive surgeries. They use various techniques to minimize the impact of surgery on a patient's quality of life, such as minimally invasive surgery, which uses small incisions and advanced technology to remove cancerous tissue with less damage to healthy tissue.

Track 18: Oncology Nursing and Care: Most cancers remedies and therapies are primarily based on kind of cancer someone is suffering from. The major treatments are surgery, radiotherapy, chemotherapy, immunotherapy, hormonal therapy, centered remedy, laser remedy, palliative care, stem mobile transplant and precision remedy. There also are a few vaccines to deal with a positive type of cancer including Human papillomavirus vaccine and hepatitis B vaccine.

Track 19: AI Algorithms in breast Cancer: Scientists have developed AI tools to aid screening exams for numerous kinds of cancer, together with breast cancer. AI-primarily based laptop packages were used to help docs interpret mammograms for greater than 20 years, but studies in this vicinity is quickly evolving. The Breast cancers version with ML algorithms. The model may be used for the prediction of benign and malignant most cancers cells.

Cancer Societies: Dutch Society for Surgical Oncology | Childhood Cancer Research Group | Association of Population-based Cancer Registries in Germany | French Society of Radiation Oncology |

Benefits of Participation

Advantages of Participating at our conference

The advantage the Speaker & Abstract pages created in Google on your profile under your name would get worldwide visibility
Our robust online publicity attracts 30000+ users and 50000+ views to our Library of Abstracts which brings worldwide exposure to the researchers and speakers participate in our conferences
Meet and exchange ideas with hundreds of like-minded professionals who are leaders in Hematology.
All the conference participants will have a different excuse to participate at one-to-one meeting with eminent Speakers and renowned keynote speakers.
A unique opportunity to listen what the worldwide researchers are talking about at our Keynote sessions by world’s most eminent researchers in the field of Hematology.
Hematology Congress intensive conference schedule, you will access strategic gift planning knowledge and expertise that’s worth its weight golf form an impressive array of recognized professionals.
Top Industries Representation of Industrial Leaders, where you get a great opportunity to meet and discuss with the Industrial Leaders in person
Exposure to Symposia’s, Workshops on carrier development and Preconference workshops in all major countries
Nominations for Best Poster Award
Outstanding Young Researcher Award
Group Registration benefits
Benefits of Participation- Speaker

Worldwide acknowledgment of Researcher’s profile
Obtain professional development credits
Explore the best in Cutting edge Research
Make Lasting connections at Networking and Social Events
An opportunity to give One page advertisement in abstract book and flyers distribution which eventually gets 1 Million views and add great value to your research profile
Learn beyond your field of interest, a change to know more about the new topics and research apart from your core subject from Hematology.
We provide unique convergence of Networking, Learning and Fun into a single package
Benefits of Participation- Delegate
Professional Development –Uplift the knowledge and skills
Conference attendance inspires, rejuvenates, and energizes delegates
Your participation at our conference will be helpful for a new approach and ideology that can be utilized for the extending the outcome of companies or industries.
Opportunities to meet through online webinar for Hematology Congress researchers and experts of same field and share new ideas
Benefit of Participation- Sponsor
Exposure to the international atmosphere will increase the odds of getting new business
Opportunity to showcase the new technology, new products of your company, or the service your industry to a broad international participants.
World’s No. 1 platform to show case Hematology products.
Increase business by lead generation through our conference participants.
Build a successful business takes a lot of time, effort and drive, so it’s always good to have a network of colleagues and associates to draw energy from people who share a similar drive and objective.
Hematology conferences create opportunities for greater focus and reflection that could help you take your business to the next level.
Benchmarking key strategies for business and moving it forward
Get answers to your business questions and challenges from credible individuals at our conference
Real Benefits in New business-Many Organizations make deals and sign contracts at our Hematology Congress.
Promotional logo of your organization at our conference banner, website and other proceedings, branding and marketing material
Benefit of Association for Collaborators
No one in the world have this huge visitors towards Hematology, this is the best platform to showcase the society
Create long-lasting relationships with the peers
Promotional content and Logo of your Association at our conference banner, website and other proceedings, branding and marketing material will increase your subscribers/Members number by 40%.
Our event visibility to your Organization page can give a great impact for your association in the Global Market forum.
Your representatives can network with key conference delegates to update their knowledge and understanding of your organization and services.
Details will be incorporated with Hematology promotional materials like flyers, brochure, pamphlets, program which will be distributed to Hospitals, Universities, Society and Researchers

Market Analysis

Conferences invite all the actors through the world to fix at International Conference on Cancer Biology and Therapeutics that goes to be listed on November 08-09, 2023 in Budapest, Hungary which is suitable to embrace keynote shows, Oral addresses, Bill shows, and Exhibitions. CANCER BIOLOGY 2023 may be an especially designed cluster conference. The most focus of the conference is “Advancement of Cancer Biology and Eradication of Cancer” that covers a large vary of critically necessary sessions.

Research and Development

Scientific improvements in understanding rare cancers that lead to new rectifiers and a probative biomedical Eco-system that provides backing and support for R&D especially among arising biopharma companies, have redounded in a channel of nearly implicit cancer treatments, over 75 since 2015.

Bringing Scientific Advances to Cancer Cases

Access to drugs has been steadily adding and 9.2 billion Defined diurnal Boluses were delivered encyclopedically in 2020, but variability across countries remains high and the use of prophetic biomarkers to effectively deliver perfection drugs to those who'll profit from them remains variable across cancer types and countries.

Spending on Oncology Medicines

The swell in invention treatments in recent times, accompanied by a strong focus across health systems to increase early opinion and expanded patient access to treatments, has redounded in global spending on oncology medicines reaching$ 164 billion in 2020 and an estimated$ 269 billion by 2025 indeed as periodic growth rates ease to about 10.

Exhibition 52 Globle oncology spending growth to exceed$ 260 billion by 2025, with growth decelerating to 9 – 12 from biosimilar savings.